|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0026882,
umls-concept:C0040732,
umls-concept:C0079419,
umls-concept:C0205225,
umls-concept:C0220825,
umls-concept:C0242957,
umls-concept:C0332293,
umls-concept:C0439859,
umls-concept:C1328050,
umls-concept:C1514307,
umls-concept:C1514559,
umls-concept:C1516213
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-6-15
|
|
pubmed:abstractText |
To ascertain the predictive value of Her-2/neu overexpression and p53 mutations, assessed by immunohistochemistry, in high-risk primary breast cancer (HRPBC) treated with high-dose chemotherapy (HDCT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BearmanS ISI,
pubmed-author:CagnoniP JPJ,
pubmed-author:CookBB,
pubmed-author:JonesR BRB,
pubmed-author:McDermitJJ,
pubmed-author:MurphyJJ,
pubmed-author:NawazSS,
pubmed-author:NietoYY,
pubmed-author:RussellPP,
pubmed-author:ShpallE JEJ,
pubmed-author:YerushalmiRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2070-80
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:10811672-Adult,
pubmed-meshheading:10811672-Aged,
pubmed-meshheading:10811672-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10811672-Breast Neoplasms,
pubmed-meshheading:10811672-Chi-Square Distribution,
pubmed-meshheading:10811672-Female,
pubmed-meshheading:10811672-Gene Expression,
pubmed-meshheading:10811672-Genes, p53,
pubmed-meshheading:10811672-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10811672-Humans,
pubmed-meshheading:10811672-Immunohistochemistry,
pubmed-meshheading:10811672-Lymphatic Metastasis,
pubmed-meshheading:10811672-Middle Aged,
pubmed-meshheading:10811672-Mutation,
pubmed-meshheading:10811672-Predictive Value of Tests,
pubmed-meshheading:10811672-Proportional Hazards Models,
pubmed-meshheading:10811672-Receptor, erbB-2,
pubmed-meshheading:10811672-Risk Factors,
pubmed-meshheading:10811672-Survival Analysis,
pubmed-meshheading:10811672-Transplantation, Autologous,
pubmed-meshheading:10811672-Tumor Markers, Biological
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
|
|
pubmed:affiliation |
University of Colorado Bone Marrow Transplant Program and Departments of Pathology and Biostatistics, University of Colorado, Denver 80262, USA. yago.nieto@uchsc.edu
|
|
pubmed:publicationType |
Journal Article
|
